Keyphrases
Adverse Events
14%
Airway
14%
Airway Lead
7%
Allergic Bronchopulmonary Aspergillosis
7%
Antibiotic Resistance
7%
Antibiotic Therapy
7%
Antibiotics
7%
Azithromycin
21%
Bacterial Colonization
7%
Bacterial Eradication
7%
Bacterial Infection
7%
Beneficial Outcomes
7%
Breathlessness
7%
Bronchiectasis
100%
Bronchography
7%
Cardiovascular Mortality
7%
Chest Radiograph
7%
Chronic Cough
7%
Chronic Respiratory Diseases
7%
Clarithromycin
7%
Cochrane
14%
Confidence Interval
100%
Continuous Data
7%
Continuous Dose
7%
Cystic Fibrosis
7%
Dichotomous Data
7%
Dilatation
7%
Electronic Search
7%
Erythromycin
14%
Exacerbation Rate
21%
Gastroenteritis
7%
Group Randomized Controlled Trial
7%
Hemoptysis
7%
High Dose
7%
High-resolution Computed Tomography
7%
Hospitalization
21%
Inflammation
7%
Long-term Management
7%
Lung Function
7%
Macrolide Antibiotics
100%
Macrolide Resistance
7%
Macrolide Therapy
7%
Macrolides
85%
Methodological Procedures
7%
Microbial Resistance
7%
Non-respiratory
7%
Number of Participants
7%
Number-needed-to-treat
7%
Odds Ratio
92%
Placebo
57%
Plain Film
7%
Pneumonia
7%
Quality of Life
14%
Quality of Life Improvement
14%
Randomized Controlled Trial
14%
Ratio Data
7%
Resistant Bacteria
7%
Respiratory Infection
7%
Review Authors
14%
Risk of Bias
7%
Roxithromycin
14%
Sarcoidosis
7%
Search Methods
7%
Selection Criteria
7%
Serious Adverse Events
28%
Small Airways
7%
Sputum Production
7%
Standardized Mean Difference
7%
Staphylococcus Aureus
7%
Streptococcus Pneumoniae
7%
Structural Damage
7%
Trial Registries
7%
Medicine and Dentistry
Adverse Event
33%
Allergic Bronchopulmonary Aspergillosis
5%
Antibiotic Resistance
5%
Antibiotic Therapy
5%
Antibiotics
100%
Azithromycin
16%
Bacterial Clearance
5%
Bacterial Colonization
5%
Bacterial Infection
5%
Bronchiectasis
100%
Bronchography
5%
Cardiovascular System
5%
Chronic Cough
5%
Chronic Respiratory Tract Disease
5%
Clarithromycin
5%
Cystic Fibrosis
5%
Drug Megadose
5%
Dyspnea
5%
Erythromycin
11%
Gastroenteritis
5%
Hemoptysis
5%
High-Resolution Computed Tomography
5%
Lung
5%
Macrolide
100%
Numbers Needed to Treat
5%
Odds Ratio
72%
Placebo
44%
Pneumococcal Pneumonia
5%
Quality of Life
22%
Randomized Controlled Trial
16%
Respiratory Tract Infection
5%
Roxithromycin
11%
Sarcoidosis
5%
Sputum
5%
Staphylococcus Aureus
5%
Streptococcus Pneumonia
5%
Thorax Radiography
5%
Nursing and Health Professions
Adverse Event
33%
Allergic Bronchopulmonary Aspergillosis
5%
Antibiotic Therapy
5%
Antimicrobial Resistance
11%
Azithromycin
16%
Bacterial Clearance
5%
Bacterial Infection
5%
Bronchiectasis
100%
Bronchography
5%
Chronic Cough
5%
Chronic Respiratory Tract Disease
5%
Clarithromycin
5%
Computer Assisted Tomography
5%
Confidence Interval
77%
Cystic Fibrosis
5%
Dilatation
5%
Drug Megadose
5%
Dyspnea
5%
Erythromycin
11%
Film
5%
Gastroenteritis
5%
Hemoptysis
5%
Inflammation
5%
Macrolide
100%
Numbers Needed to Treat
5%
Odds Ratio
72%
Placebo
44%
Quality of Life
22%
Respiratory Tract Infection
5%
Roxithromycin
11%
Sarcoidosis
5%
Streptococcus Pneumonia
5%
Thorax Radiography
5%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
33%
Allergic Bronchopulmonary Aspergillosis
5%
Antibiotic Therapy
5%
Antibiotics
100%
Antimicrobial Resistance
11%
Azithromycin
16%
Bacterial Clearance
5%
Bacterial Infection
5%
Bronchiectasis
100%
Chronic Cough
5%
Chronic Respiratory Tract Disease
5%
Clarithromycin
5%
Cystic Fibrosis
5%
Dyspnea
5%
Erythromycin
11%
Gastroenteritis
5%
Hemoptysis
5%
Inflammation
5%
Macrolide
100%
Number Needed to Treat
5%
Placebo
44%
Randomized Controlled Trial
16%
Respiratory Tract Infection
5%
Roxithromycin
11%
Sarcoidosis
5%
Staphylococcus Aureus
5%
Streptococcus Pneumonia
5%